어플

The FTC has launched an on-site investigation into Ottogi and Guangdong Pharmaceutical on charges of unfair internal transactions

Business / 김지선 / 09/15/2023 03:00 AM
 

 

[Alpha Biz=(Chicago) Reporter Kim Jisun] The Fair Trade Commission has launched an investigation into allegations of unfair support by mid-sized companies such as Ottogi and Kwangdong Pharmaceutical.

According to the industry, the FTC sent investigators to Ottogi and Guangdong Pharmaceutical on the 14th.

The FTC is said to have detected allegations of unfair support from a number of groups as a result of monitoring the status of internal transactions by mid-sized business groups.

Mid-sized business groups have lax external monitoring and a higher proportion of the total family members within the board of directors than large business groups with assets of 5 trillion won or more.

 

 

AlphaBIZ 김지선(stockmk2020@alphabiz.co.kr)

Related articles

[Exclusive] Samsung Electronics to Supply HBM3E 12-High Stacks to NVIDIA
DL E&C Executives Resign En Masse Following Fatal Construction Site Accident
POSCO Future M Terminates KRW 945 Billion ESS Cathode Material Supply Contract, Signs New LFP Partnership with CNGR
Hahn & Company Selects TKG Taekwang as Preferred Bidder for Sale of Semiconductor Parts Maker Solmix
Hyundai Motor Group Bolsters SDV and Autonomous Driving Capabilities with KRW 500.3 Billion Investment in 42dot
comments >

SNS